**Summary of Fevertree Drinks PLC FY25 Interim Results to 30 June 2025**
Fevertree Drinks PLC reported its FY25 interim results, highlighting **strategic progress** and **alignment with full-year expectations**. Key highlights include
### **Strategic Partnerships & Growth**
**Molson Coors Partnership**A long-term strategic partnership signed in January 2025 grants Molson Coors exclusive rights to sell, distribute, and produce Fever-Tree products in the U.S. The transition to Molson Coors national distributor network began in June and is progressing well.
**Product Diversification**Beyond tonic, products like Ginger Beer and Premium Soft Drinks are driving growth, now representing **45% of Group revenues**.
### **Financial Performance**
**Revenue**Total adjusted revenue grew **2%** to £172.2 million (constant currency), with Fever-Tree brand revenue up **2%** to £171.0 million.
**Adjusted EBITDA**Increased **1%** to £18.4 million, with margins improving by **20bps** to 10.7%.
**Cash Position**Significantly enhanced to **£130.0 million** (up **97%**) due to strong cash flow and inflows from the Molson Coors transaction.
**Dividend**Interim dividend increased **2%** to 5.97 pence per share.
### **Regional Performance**
**U.S.**Revenue grew **6%** (constant currency) despite transition complexities. Retail sales outpaced the market, with "core four" mixers growing **16%**.
**UK**Revenue declined **6%** due to On-Trade challenges, but Off-Trade remained robust with strong growth in premium soft drinks and cocktail mixers.
**Europe**Revenue flat year-on-year, but Ginger Beer saw **26%** growth, solidifying Fever-Trees leadership.
**Rest of the World**Revenue grew **17%** (constant currency), driven by Australia and Canada.
### **Strategic Initiatives**
**Share Buyback**Extended by **£30 million** to 2026, reflecting confidence in earnings quality.
**Sustainability**Science-based targets validated by SBTi, with progress in packaging circularity and conservation.
### **Outlook**
The Group is on track to meet full-year expectations, with a strong start to the second half. The Molson Coors partnership is expected to drive long-term growth in the U.S., while diversification and operational improvements position Fevertree for sustained success.
**CEO Tim Warrillow** emphasized the significance of the Molson Coors partnership and the brands ability to straddle adult socialising occasions, aligning with consumer trends like premiumisation and moderation.
**Key Metrics**
Revenue£172.2 million (+2% constant currency)
Adjusted EBITDA£18.4 million (+1%)
Cash£130.0 million (+97%)
Diluted EPS6.82 pence (+5%)
Interim Dividend5.97 pence (+2%)
Fevertree remains confident in its strategic direction and long-term growth prospects.